Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
T-cell therapy
Biotech
Wugen woos VCs, landing $115M to bring CAR-T therapy to market
Wugen is running a pivotal trial to support a 2027 FDA filing for what could be the first off-the-shelf CAR-T for T-cell malignancies.
Nick Paul Taylor
Aug 27, 2025 8:10am
Allogene lays off 28% of staff to save cash amid program delays
May 14, 2025 8:00am
Kiromic furloughs 'substantially all' workers amid cash crunch
Mar 18, 2025 5:42am
Otsuka gives cancer candidates the kiss-off on strategic grounds
Feb 14, 2025 5:30am
Janux's T-cell engager makes waves, again, with new data drop
Dec 3, 2024 11:40am
BMS' CAR-T cracks down on lupus, achieving sustained responses
Nov 14, 2024 10:00am
